Interview: “Oncology Trials are Different”

 

“Oncology trials are different” states Dr Johann Proeve, our Chief Scientific Officer, in his latest video interview about “one-size doesn’t fit all” when it comes to risk management. Many risks in clinical trials seem therapy specific. To illustrate this, Johann shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.

Take a peek: Interview – Oncology Trials are Different

See also: Oncology Risk Assessment and Categorization Tool (OncoRACT)

By |2018-10-02T05:41:24+00:00May 3, 2018|Blog, News|Comments Off on Interview: “Oncology Trials are Different”
Linda has over 20 years of experience uncovering pain points and strategizing with MedTech organisations in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all project activities meet our clients’ quality expectations.

Upcoming Events

  1. Frontiers Health 2018

    November 15 - November 16
  2. PCT Europe 2018

    November 28 - November 29

Register Today!

Get Free Test Access